Rhine Shen

5PUBLICATIONS
61CO-AUTHORS
Molecular targetsChemotherapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 24, 2026
Genomic correlates of clinical CAR T cell activity.

|Jul 21, 2026
Model-Based Analysis with Mechanistic Insights to CAR-T-Cell Therapy Kinetics: Case Study with Axicabtagene Ciloleucel and Brexucabtagene Autoleucel.

|Oct 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3.

Tom van Meerten, Marie José Kersten, Gloria Iacoboni

|Oct 16, 2025
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.

Sattva S Neelapu, Julio C Chavez, Alison R Sehgal

|Nov 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7).

Simone Filosto, Saran Vardhanabhuti, Miguel A Canales

Pageof 1

Frequent Collaborators

2 joint publications

Simone Filosto

2 joint publications

Justin Budka

1 joint publications

Saran Vardhanabhuti

1 joint publications

Miguel A Canales